Orphazyme Feed

Land	Danmark
Lista	Small Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2022-09-26 17:25:29 Orphazyme reports financial results in Interim Report First Half 2022 +6,15% | 0,07 MDKK

2022-09-25 22:09:16 Adjusted financial outlook for 2022 -4,76% | 0,10 MDKK

2022-09-19 19:41:51 Updated financial calendar for 2022 +2,08% | 0,17 MDKK

2022-06-29 16:27:05 Resolutions passed at the Annual General Meeting -4,75% | 0,21 MDKK

2022-06-20 19:50:13 Updated notice to holders of ADSs regarding termination of Deposit Agreement +4,10% | 0,25 MDKK

2022-06-08 23:07:32 Correction: Orphazyme Announces Publication of 2021 Financial Results and Annual Report -2,17% | 0,30 MDKK

2022-06-07 23:47:03 Notice to convene Annual General Meeting -7,63% | 0,41 MDKK

2022-06-07 23:34:17 Orphazyme Announces Publication of 2021 Financial Results and Annual Report -7,63% | 0,41 MDKK

2022-05-31 18:57:57 Orphazyme completes sale of substantially all of its assets and business activities to KemPharm +22,74% | 1,23 MDKK

2022-05-30 14:55:12 Restructuring proposal adopted by creditors +31,01% | 0,54 MDKK

2022-05-23 08:52:08 Changes to the Board of Directors -5,92% | 0,23 MDKK

2022-05-18 16:35:30 Restructuring Proposal -3,74% | 0,29 MDKK

2022-05-16 14:50:25 Updated Financial Calendar for 2022 -5,30% | 1,19 MDKK

2022-05-15 23:00:00 Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. -5,30% | 1,19 MDKK

2022-04-29 08:46:58 Orphazyme announces update on in-court restructuring proceedings -0,51% | 1,45 MDKK

2022-04-28 16:13:58 Updated Financial Calendar for 2022 -1,21% | 0,32 MDKK

2022-04-07 12:08:00 Statutory restructuring plan adopted by creditors -43,34% | 2,83 MDKK

2022-04-06 14:48:42 Updated Financial Calendar for 2022 -2,52% | 1,07 MDKK

2022-04-06 10:00:00 Notice received from the Depositary to holders of ADSs regarding termination of Deposit Agreement -2,52% | 1,07 MDKK

2022-04-04 19:44:00 Correction: Proposal for a statutory restructuring plan -0,10% | 0,98 MDKK

2022-03-31 23:37:01 Voluntary delisting of ADSs has become effective -7,78% | 1,97 MDKK

2022-03-31 18:00:00 Proposal for a statutory restructuring plan -7,78% | 1,97 MDKK

2022-03-29 13:15:00 Updated Financial Calendar for 2022 +3,45% | 0,41 MDKK

2022-03-22 11:54:06 Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C +5,90% | 3,96 MDKK

2022-03-21 22:44:00 Orphazyme A/S has filed for voluntary delisting of ADSs +5,90% | 3,96 MDKK

2022-03-18 11:40:10 Notice of in-court restructuring proceedings of Orphazyme A/S +0,49% | 5,86 MDKK

2022-03-10 22:05:00 Commencement of in-court restructuring of Orphazyme A/S -34,60% | 5,18 MDKK

2022-03-03 09:35:00 Updated Financial Calender for 2022 -1,91% | 0,82 MDKK

2022-02-28 08:25:00 Anders Vadsholt takes over as CEO of Orphazyme -4,53% | 3,91 MDKK

2022-02-23 22:05:00 Orphazyme announces update on regulatory review of arimoclomol in the European Union -28,99% | 6,08 MDKK

2022-02-18 22:01:00 Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program -2,37% | 0,35 MDKK

2022-02-15 18:15:00 Resolutions passed at the Extraordinary General Meeting -0,28% | 1,23 MDKK

2022-02-14 22:01:00 Amendment of proposals put forward at the Extraordinary General Meeting -3,17% | 1,51 MDKK

2022-02-11 07:50:00 Orphazyme provides update for planned NDA resubmission for arimoclomol for the treatment of Niemann-Pick disease type C in the United States +14,39% | 10,2 MDKK

2022-02-07 12:22:37 Orphazyme to present additional data on arimoclomol’s mechanism of action during 2022 Annual WORLDSymposium™ -1,10% | 0,45 MDKK

2022-01-31 17:00:00 Changes to the Executive Management of Orphazyme – Anders Vadsholt to be appointed CEO +1,33% | 1,21 MDKK

2022-01-24 22:15:00 Notice to convene Extraordinary General Meeting +0,38% | 0,93 MDKK

2022-01-18 22:15:00 Orphazyme updates 2021 financial outlook +3,57% | 3,83 MDKK

2021-12-09 06:45:00 Orphazyme announces changes to the Board of Directors -0,29% | 1,62 MDKK

2021-11-19 09:06:46 Financial Calendar 2022 -1,98% | 3,18 MDKK

2021-11-04 13:22:00 Orphazyme establishes a U.S. At-the-Market Offering Program with Cowen -0,60% | 8,01 MDKK

2021-10-31 21:00:00 Orphazyme provides regulatory update following Type A meeting with FDA on arimoclomol in Niemann-Pick disease type C +9,00% | 51,6 MDKK

2021-10-07 08:40:00 Modified long-term share-based incentive program for 2021 -0,39% | 1,80 MDKK

2021-10-05 08:55:00 Orphazyme provides regulatory and financial updates +2,52% | 3,00 MDKK

2021-08-31 07:00:00 Orphazyme reports business highlights and financial results in Interim Report First Half 2021 -4,45% | 12,7 MDKK

2021-08-25 14:33:47 Orphazyme to host Interim Report First Half 2021 investor call on August 31, 2021 +1,92% | 7,58 MDKK

2021-08-23 11:04:34 Orphazyme announces publication of results from its Phase 2/3 trial of arimoclomol in Niemann-Pick disease type C in the Journal of Inherited Metabolic Disease +7,07% | 39,5 MDKK

2021-08-05 18:11:50 New publication date for Orphazyme’s Interim Report H1 2021 +1,02% | 6,85 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2023-09-12	Kvartalsrapport 2023-Q2
2023-04-20	Årsstämma 2023
2023-03-28	Bokslutskommuniké 2022
2022-09-26	Kvartalsrapport 2022-Q2
2022-06-29	Årsstämma 2022
2022-06-28	Ordinarie utdelning ORPHA 0.00 DKK
2022-06-07	Bokslutskommuniké 2021
2022-02-15	Extra Bolagsstämma 2022
2021-08-31	Kvartalsrapport 2021-Q2
2021-03-26	Ordinarie utdelning ORPHA 0.00 DKK
2021-03-25	Årsstämma 2021
2021-03-02	Bokslutskommuniké 2020
2020-09-21	Extra Bolagsstämma 2020
2020-08-28	Kvartalsrapport 2020-Q2
2020-03-27	Ordinarie utdelning ORPHA 0.00 DKK
2020-03-26	Årsstämma 2020
2020-02-28	Bokslutskommuniké 2019
2020-01-25	Extra Bolagsstämma 2019
2019-08-28	Kvartalsrapport 2019-Q2
2019-03-28	Ordinarie utdelning ORPHA 0.00 DKK
2019-03-27	Årsstämma 2019
2019-03-01	Bokslutskommuniké 2018
2018-08-28	Kvartalsrapport 2018-Q2
2018-04-13	Ordinarie utdelning ORPHA 0.00 DKK
2018-04-12	Årsstämma 2018
2018-03-15	Bokslutskommuniké 2017

Orphazyme

Kalender

Beskrivning

Orphazyme

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden